INVESTIGATION OF THE ROLE OF ICAM-1 E469K AND E-SELECTIN S128R POLYMORPHISMS IN DIABETIC NEUROPATHY

被引:0
作者
Oguz, Elif [1 ]
Tabur, Suzan [2 ]
Akbas, Halit [3 ]
Korkmaz, Hakan [2 ]
Torun, Aysenur [4 ]
Dilmec, Fuat [3 ]
Alasehirli, Belgin [5 ]
机构
[1] Harran Univ, Fac Med, Dept Med Pharmacol, Sanliurfa, Turkey
[2] Gaziantep Univ, Fac Med, Dept Endocrinol, Gaziantep, Turkey
[3] Harran Univ, Fac Med, Dept Med Biol, Sanliurfa, Turkey
[4] Baskent Univ, Fac Med, Dept Endocrinol, Adana, Turkey
[5] Gaziantep Univ, Fac Med, Dept Med Pharmacol, Gaziantep, Turkey
来源
ACTA MEDICA MEDITERRANEA | 2015年 / 31卷 / 05期
关键词
Diabetic peripheral neuropathy; E-selectin; intercellular adhesion molecule-1; polymorphism; INTERCELLULAR-ADHESION MOLECULE-1; CORONARY-ARTERY-DISEASE; SOLUBLE E-SELECTIN; K469E POLYMORPHISM; GENE POLYMORPHISMS; RISK-FACTORS; ASSOCIATION; MELLITUS; CELLS; SUSCEPTIBILITY;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: Diabetic peripheral neuropathy is one of the commonest complications of diabetes. The soluble adhesion molecules, E-selectin and intracellular adhesion molecule (ICAM)-are indicators for endothelial activation. Recent studies demonstrated that these molecules are increased in patients with diabetes and diabetes-related complications. The present study was designed to investigate the possible association of two mutations, S128R in E-selectin and K469E in ICAM-1 with diabetic peripheral neuropathy (DPN) in Turkish population. Materials and methods: One hundred thirty eight patients with DPN and 138 non-diabetic control subjects by similar age were enrolled in the study. Genotyping was done by polymerase chain reaction- restriction fragment length polymorphism. Results: No significant differences were found in the genotype and allele frequencies of ICAM E469K polymorphism between the groups of DPN patients and non-diabetic control subjects. There was also no statistically significant difference for E-selectin S128R polymorphism between DPN patients and non-diabetic control subjects. Conclusions: We firstly investigated the involvement ICAM-1 and E-selectin gene variants in development of DPN. These results suggested that the ICAM-1 E469K and S128R polymorphisms are not associated with susceptibility to DPN in Turkish population. Further studies in larger series and in different ethnic populations should be carried out to validate our findings.
引用
收藏
页码:1113 / 1118
页数:6
相关论文
共 38 条
[1]   The interactive role of type 2 diabetes mellitus and E-selectin S128R mutation on susceptibility to coronary heart disease [J].
Abu-Amero, Khaled K. ;
Al-Mohanna, Futwan ;
Al-Boudari, Olayan M. ;
Mohamed, Gamal H. ;
Dzimiri, Nduna .
BMC MEDICAL GENETICS, 2007, 8
[2]   Role of S128R polymorphism of E-selectin in colon metastasis formation [J].
Alessandro, Riccardo ;
Seidita, Gregorio ;
Flugy, Anna Maria ;
Damiani, Francesca ;
Russo, Antonio ;
Corrado, Chiara ;
Colomba, Paolo ;
Gullotti, Lucia ;
Buettner, Reinhard ;
Bruno, Loredana ;
De Leo, Giacomo .
INTERNATIONAL JOURNAL OF CANCER, 2007, 121 (03) :528-535
[3]   Epidemiology, public health burden, and treatment of diabetic peripheral neuropathic pain: A review [J].
Barrett, Amy M. ;
Lucero, Melanie A. ;
Le, Trong ;
Robinson, Rebecca L. ;
Dworkin, Robert H. ;
Chappell, Amy S. .
PAIN MEDICINE, 2007, 8 :S50-S62
[4]  
Blann A, 1997, CLIN HEMORHEOL MICRO, V17, P3
[5]   Diabetic neuropathies - A statement by the American Diabetes Association [J].
Boulton, AJM ;
Vinik, AI ;
Arezzo, JC ;
Bril, V ;
Feldman, EL ;
Freeman, R ;
Malik, RA ;
Maser, RE ;
Sosenko, JM ;
Ziegler, D .
DIABETES CARE, 2005, 28 (04) :956-962
[6]   Seven regions of the genome show evidence of linkage to type 1 diabetes in a consensus analysis of 767 multiplex families [J].
Cox, NJ ;
Wapelhorst, B ;
Morrison, VA ;
Johnson, L ;
Pinchuk, L ;
Spielman, RS ;
Todd, JA ;
Concannon, P .
AMERICAN JOURNAL OF HUMAN GENETICS, 2001, 69 (04) :820-830
[7]   The E-selectin S128R polymorphism is not a risk factor for coronary artery disease in patients with diabetes mellitus type 2 [J].
Endler, G ;
Exner, M ;
Raith, M ;
Marculescu, R ;
Mannhalter, C ;
Endler, L ;
Wojta, J ;
Huber, K ;
Wagner, OF .
THROMBOSIS RESEARCH, 2003, 112 (1-2) :47-50
[8]  
Guja C, 1999, DIABETOLOGIA, V42, P327
[9]   Validity of biomarkers predicting onset or progression of nephropathy in patients with Type 2 diabetes: a systematic review [J].
Hellemons, M. E. ;
Kerschbaum, J. ;
Bakker, S. J. L. ;
Neuwirt, H. ;
Mayer, B. ;
Mayer, G. ;
de Zeeuw, D. ;
Lambers Heerspink, H. J. ;
Rudnicki, M. .
DIABETIC MEDICINE, 2012, 29 (05) :567-577
[10]  
JOLING P, 1994, ADV EXP MED BIOL, V355, P131